scispace - formally typeset
C

Claudia Giambartolomei

Researcher at Istituto Italiano di Tecnologia

Publications -  60
Citations -  6897

Claudia Giambartolomei is an academic researcher from Istituto Italiano di Tecnologia. The author has contributed to research in topics: Genome-wide association study & Expression quantitative trait loci. The author has an hindex of 24, co-authored 53 publications receiving 4676 citations. Previous affiliations of Claudia Giambartolomei include University of California, Los Angeles & University of London.

Papers
More filters
Journal ArticleDOI

Bayesian test for colocalisation between pairs of genetic association studies using summary statistics.

TL;DR: A novel statistical methodology to assess whether two association signals are consistent with a shared causal variant and the ability to derive the output statistics from single SNP summary statistics, making it possible to perform systematic meta-analysis type comparisons across multiple GWAS datasets is developed.
Journal ArticleDOI

Genome-wide association study identifies 30 loci associated with bipolar disorder

Eli A. Stahl, +342 more
- 01 May 2019 - 
TL;DR: Genome-wide analysis identifies 30 loci associated with bipolar disorder, allowing for comparisons of shared genes and pathways with other psychiatric disorders, including schizophrenia and depression.
Journal ArticleDOI

Mendelian randomization of blood lipids for coronary heart disease

Michael V. Holmes, +67 more
TL;DR: The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.
Journal ArticleDOI

Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes

Douglas M. Ruderfer, +631 more
- 14 Jun 2018 - 
TL;DR: For the first time, specific loci that distinguish between BD and SCZ are discovered and polygenic components underlying multiple symptom dimensions are identified that point to the utility of genetics to inform symptomology and potential treatment.
Journal ArticleDOI

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

Daniel I. Swerdlow, +132 more
- 24 Jan 2015 - 
TL;DR: The increased risk of type 2 diabetes noted with statins is at least partially explained by HMGCR inhibition.